Search Results for: PTEN

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PCNA proliferating cell nuclear antigen
  • Translesion synthesis by REV1
  • Recognition of DNA damage by PCNA-containing replication complex
  • Translesion Synthesis by POLH
  • Transcription of E2F targets under negative control by DREAM complex
  • Polymerase switching on the C-strand of the telomere
  • Processive synthesis on the C-strand of the telomere
  • Telomere C-strand (Lagging Strand) Synthesis
  • Removal of the Flap Intermediate from the C-strand
  • SUMOylation of DNA replication proteins
  • Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
  • Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
  • PCNA-Dependent Long Patch Base Excision Repair
  • Translesion synthesis by POLK
  • Translesion synthesis by POLI
  • Termination of translesion DNA synthesis
  • HDR through Homologous Recombination (HRR)
  • Gap-filling DNA repair synthesis and ligation in GG-NER
  • Dual Incision in GG-NER
  • Dual incision in TC-NER
  • Gap-filling DNA repair synthesis and ligation in TC-NER
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Polymerase switching
  • Removal of the Flap Intermediate
  • Processive synthesis on the lagging strand
  • G1/S-Specific Transcription
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Liothyronine
  • Acetylsalicylic acid
PHB prohibitin
  • RAF activation
  • Signaling by moderate kinase activity BRAF mutants
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Processing of SMDT1
  • Signaling downstream of RAS mutants
  • Rocaglamide
  • Didesmethylrocaglamide
PRKDC protein kinase, DNA-activated, catalytic subunit
  • Cytosolic sensors of pathogen-associated DNA
  • IRF3-mediated induction of type I IFN
  • Nonhomologous End-Joining (NHEJ)
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Caffeine
  • SF1126
SLC25A5 solute carrier family 25 member 5
  • Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
  • Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
  • Clodronic acid
  • Etidronic acid
SMARCA5 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
  • NoRC negatively regulates rRNA expression
  • B-WICH complex positively regulates rRNA expression
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Beta-D-Glucose
  • 4-Deoxy-Alpha-D-Glucose
SPTBN1 spectrin beta, non-erythrocytic 1
  • Nephrin family interactions
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • RAF/MAP kinase cascade
  • COPI-mediated anterograde transport
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 fusion proteins
  • Calcium
  • 1D-myo-inositol 1,4,5-trisphosphate
YES1 YES proto-oncogene 1, Src family tyrosine kinase
  • Signaling by ERBB2
  • Signaling by SCF-KIT
  • Signaling by SCF-KIT
  • Regulation of KIT signaling
  • FCGR activation
  • PECAM1 interactions
  • EPH-Ephrin signaling
  • CD28 co-stimulation
  • CTLA4 inhibitory signaling
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • RUNX2 regulates osteoblast differentiation
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated phagocytosis
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Dasatinib
  • Fostamatinib
ARF4 ADP ribosylation factor 4
  • VxPx cargo-targeting to cilium
  • VxPx cargo-targeting to cilium
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • Guanosine-5'-Diphosphate
CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
  • Pyrimidine biosynthesis
  • Sparfosic acid
CMAS cytidine monophosphate N-acetylneuraminic acid synthetase
  • Sialic acid metabolism
  • Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid
CSNK1A1 casein kinase 1 alpha 1
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Signaling by GSK3beta mutants
  • S33 mutants of beta-catenin aren't phosphorylated
  • S37 mutants of beta-catenin aren't phosphorylated
  • S45 mutants of beta-catenin aren't phosphorylated
  • T41 mutants of beta-catenin aren't phosphorylated
  • APC truncation mutants have impaired AXIN binding
  • AXIN missense mutants destabilize the destruction complex
  • Truncations of AMER1 destabilize the destruction complex
  • Degradation of GLI2 by the proteasome
  • GLI3 is processed to GLI3R by the proteasome
  • Activation of SMO
  • Activation of SMO
  • Fostamatinib
EIF6 eukaryotic translation initiation factor 6
  • Copper
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Lethal congenital contractural syndrome (LCCS)
  • Type I diabetes mellitus
FARSA phenylalanyl-tRNA synthetase subunit alpha
  • Cytosolic tRNA aminoacylation
  • Phenylalanine
FARSB phenylalanyl-tRNA synthetase subunit beta
  • Cytosolic tRNA aminoacylation
  • Phenylalanine
HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
  • Acyl chain remodeling of CL
  • Beta oxidation of myristoyl-CoA to lauroyl-CoA
  • mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
  • Beta oxidation of palmitoyl-CoA to myristoyl-CoA
  • Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
  • Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
  • Beta oxidation of octanoyl-CoA to hexanoyl-CoA
  • Beta oxidation of hexanoyl-CoA to butanoyl-CoA
  • NADH
  • Disorders of fatty-acid oxidation, including: Medium-chain (MC) acyl-CoA dehydrogenase (AD) deficiency (MCADD); Short-chain AD deficiency (SCADD) ; Short-branched-chain AD deficiency (SBCADD) ; Very long-chain AD deficiency (VLCADD) ; Long-chain 3-hydroxyacyl CoA dehydrogenase deficiency (LCHADD) ; Trifunctional protein deficiency (TFP); Carnitine palmitoyltransferase deficiency (CPT); Carnitine-acylcarnitine translocase deficiency (CACT); Systemic primary carnitine deficiency (CDSP)
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
HSPA4 heat shock protein family A (Hsp70) member 4
  • Regulation of HSF1-mediated heat shock response
  • Phenethyl Isothiocyanate
HSPD1 heat shock protein family D (Hsp60) member 1
  • Mitochondrial protein import
  • Mitochondrial protein import
  • TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
  • Copper
  • Hereditary spastic paraplegia (SPG)
  • Hypomyelinating leukodystrophy (HLD); Pelizaeus-Merzbacher disease (PMD)
HSPH1 heat shock protein family H (Hsp110) member 1
  • Scavenging by Class F Receptors
  • Scavenging by Class F Receptors
  • Regulation of HSF1-mediated heat shock response
  • Phenethyl Isothiocyanate
LATS1 large tumor suppressor kinase 1
  • Signaling by Hippo
  • Fostamatinib

Page 4 out of 19 pages